From: CircRNAs in anticancer drug resistance: recent advances and future potential
Classification | Drug | Cancer | CircRNAs | Mechanism | Role | Ref |
---|---|---|---|---|---|---|
Endocrine Drugs | Enzalutamide | Prostate Cancer | circ_0004870 | U2AF65/AR-V7 axis | Down | [165] |
circRNA17 | Maintaining stability of miR-181c-5p | Down | [166] | |||
circUCK2 | MiR-767-5p/TET1 axis | Down | [167] | |||
Tamoxifen | Breast Cancer | circ_0025202 | MiR-182-5p/FOXO3a axis | Down | [172] | |
circBMPR2 | MiR-553/USP4 axis | Down | [174] | |||
Targeted drugs | Gefitinib | NSCLC | circ_0109320 | NA | Down | [179] |
circ_0004015 | MiR-1183/PDPK1 axis | Up | [180] | |||
Imatinib | Chronic Myeloid Leukemia | circBA9.3 | Upregulate the ABL1 and BCRABL1 protein expression | Up | [190] | |
circ_100053 | NA | Up | [191] | |||
Immune drugs | PD-1 inhibitor | NSCLC | circFGFR1 | MiR-381-3p/CXCR4 axis | Up | [199] |